Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc.

FHTX | NASDAQ
Chart Builder DCF Calculator
$4.15
+$0.01 (+0.24%)
At close: Sep 21, 2026, 4:00 PM ET
$4.25
+$0.10 (+2.41%)
After-hours: Sep 21, 2026, 7:41 PM ET

Market Data

Market Cap
$243.66M
Enterprise Value
$119.18M
Beta
2.86
Average Volume
275.58K
Shares Outstanding (Diluted)
70.63M
Shares Change YoY
12.15%
Institutional Ownership
63.91%
Exchange
NASDAQ
ISIN
US3441741077

Price Performance

Price Change 1M
-42.5%
Price Change 3M
0.2%
Price Change 6M
-15.8%
Price Change YTD
-20.0%
Price Change 1Y
-16.7%
Price Change 3Y
-31.4%
Price Change 5Y
-70.8%
1M CAGR (ann.)
-31.6%
1Y CAGR (ann.)
-19.3%
5Y CAGR (ann.)
-19.9%
All-Time CAGR
-22.1%

Valuation

PE Ratio
-4.19
Forward PE
N/A
PEG Ratio
-0.23
Forward PEG
-0.35
PS Ratio
6.63
Forward PS
7.40
PB Ratio
-3.01
P/FCF Ratio
-2.85
P/Adj. FCF Ratio
-2.63
P/OCF Ratio
-3.43
EV/Sales
3.24
EV/EBIT
-1.85
EV/EBITDA
-1.91
EV/FCF
-1.40
Earnings Yield
-23.9%
FCF Yield
-35.0%
Adj. FCF Yield
-38.0%

Financial Health

Net Cash
$124.48M
Total Debt
$43.1M
Cash & Short-Term Investments
$167.58M
Total Assets
$203.39M
Current Ratio
3.36
Quick Ratio
3.36
Debt / Equity Ratio
-0.53
Debt / EBITDA
-0.69
Debt / FCF
-0.51
OCF / Debt
-1.98
Interest Coverage
0.00
Altman Z-Score
-4.19
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
42.7%
Operating Profit Margin
-186.4%
EBITDA Margin
-170.1%
Net Profit Margin
-175.8%
FCF Margin
-232.3%
Adj. FCF Margin
-251.8%
SBC / Revenue
19.5%
SBC Impact (per share)
-8.4%

Returns

Return on Assets
-31.8%
Return on Equity
72.6%
Return on Invested Capital
-44.0%
Return on Capital Employed
-44.8%
Return on Tangible Assets
-31.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
19.1%
Revenue CAGR 5Y
105.8%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
34.8%
EPS CAGR 5Y
-64.8%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
12.8%
FCF CAGR 5Y
-183.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
9
EPS Growth Next 3Y
12.1%
Revenue Growth Next 3Y
0.8%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
-$0.22
EPS Growth Est (next Q)
-12.0%
Revenue Est (next Q)
$7.09M
Revenue Growth Est (next Q)
-13.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$13.86
Price Target Upside
234.0%

Cash Flow

Operating Cash Flow
$-85.3M
Free Cash Flow
$-85.35M
Adj. Free Cash Flow
$-92.52M
FCF Per Share
-$1.21
OCF Per Share
-$1.21
OCF/S Ratio
-232.2%

Income Statement

Revenue
$36.74M
Gross Profit
$15.7M
Operating Income
$-68.48M
EBITDA
$-62.49M
Net Income
$-64.58M
EPS (Diluted)
-$0.99
Revenue / Employee
$346.59K
Profit / Employee
$-609.24K
Employees
106

© 2026 bestshares.com. All rights reserved.